Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Imaging01:14

Brain Imaging

670
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
670

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments.

Biometrics·2026
Same author

Reply: Matters Arising: The importance of understanding AI's impact on physician behavior.

Npj mental health research·2025
Same author

Brain activity explains message effectiveness: A mega-analysis of 16 neuroimaging studies.

PNAS nexus·2025
Same author

A novel experimental vignette methodology: SMART vignettes.

Methodological innovations·2025
Same author

Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.

Journal of affective disorders·2025

Related Experiment Video

Updated: Jan 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.2K

Developing Clinically Interpretable Neuroimaging Biotypes in Psychiatry.

Jeesung Ahn1, Lara Foland-Ross1, Teddy J Akiki2

  • 1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.

Biological Psychiatry
|September 10, 2025
PubMed
Summary
This summary is machine-generated.

Functional magnetic resonance imaging (fMRI) can predict major depressive disorder (MDD) treatment outcomes. Matching treatments to individual brain circuit profiles may double remission rates, improving care for this disabling condition.

Keywords:
Depression biotypesFunctional neuroimagingNeural circuitsPrecision medicine in psychiatryTreatment

More Related Videos

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.8K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.5K

Related Experiment Videos

Last Updated: Jan 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.2K
Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
04:25

Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies

Published on: December 15, 2023

3.8K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.5K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Major depressive disorder (MDD) is a leading cause of disability, characterized by heterogeneous patient presentations and a lack of biomarkers for guiding treatment.
  • Current diagnostic and treatment approaches for MDD rely on symptom-based assessments and trial-and-error prescribing, leading to low initial remission rates (33%) and high relapse risks (50-90%).
  • The heterogeneity of MDD necessitates the development of objective methods to personalize treatment selection and improve patient outcomes.

Purpose of the Study:

  • To review and synthesize studies demonstrating the utility of functional magnetic resonance imaging (fMRI) in predicting treatment response for MDD.
  • To illustrate a specific fMRI-based method for quantifying brain circuit dysfunction and its application in personalized treatment matching.
  • To discuss the potential of precision imaging approaches in addressing MDD heterogeneity and improving clinical practice.

Main Methods:

  • A critical review of existing literature on fMRI applications in predicting MDD treatment outcomes.
  • Illustration of a theoretically informed approach quantifying dysfunction across six large-scale biotype circuits using fMRI.
  • Analysis of personalized circuit scores as predictors of treatment response and moderators of differential treatment outcomes.

Main Results:

  • fMRI-based personalized circuit scores can predict treatment response or failure in individuals with MDD.
  • Matching treatments to an individual's specific brain circuit profile (biotype) has the potential to double remission rates compared to standard, unmatched treatments.
  • This approach offers a biological basis for parsing the heterogeneity of MDD, moving beyond symptom-based classification.

Conclusions:

  • fMRI-based biomarkers hold significant promise for personalizing MDD treatment and improving remission rates.
  • Translating these precision imaging tools into routine clinical practice requires addressing current challenges and limitations.
  • Future research should focus on refining fMRI methodologies and validating their clinical utility for MDD management.